Las concentraciones séricas de interleucina-6 y proteína C reactiva se incrementan a medida que la enfermedad de Chagas evoluciona hacia el deterioro de la función cardíaca

López, Lyankis; Arai, Kaduo; Jiménez, Esther; Jiménez, Mariela; Pascuzo, Carmine; Rodríguez-Bonfante, Claudina; Bonfante-Cabarcas, Rafael.
Rev. esp. cardiol. (Ed. impr.) ; 59(1): 50-56, ene. 2006. tab, graf
Artículo en Es | IBECS (España) | ID: ibc-042487

Documentos relacionados

  1. A 12-mer repetitive antigenic epitope from Trypanosoma cruzi is a potential marker of therapeutic efficacy in chronic Chagas' disease.
  2. [C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure].
  3. Prognosis of chronic Chagas heart disease and other pending clinical challenges.
  4. Updated review on the pathophysiology of Chagas cardiomyopathy.
  5. Myocardial fibrosis in chagas disease and molecules related to fibrosis.
  6. Prognostic impact of Chagas disease in the United States.
  7. Screening of at-risk blood donors for Chagas disease in non-endemic countries: Lessons from a 2-year experience in Tuscany, Italy.
  8. [Chagasic Cardiopathy in a child: Case report].
  9. Echocardiographic parameters, speckle tracking, and brain natriuretic peptide levels as indicators of progression of indeterminate stage to Chagas cardiomyopathy.
  10. Interleukin-10 and tumour necrosis factor-alpha serum levels in chronic Chagas disease patients.